Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FRESENIUS SE : Buy rating from Goldman Sachs

06/10/2021 | 08:31am EDT

Goldman Sachs is positive on the stock with a Buy rating. The target price remains unchanged at EUR 46.


ę MarketScreener with dpa-AFX Analyser 2021
All news about FRESENIUS SE & CO. KGAA
07/23FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies gives a Sell rating
MD
07/23FRESENIUS SE : Jefferies reiterates its Sell rating
MD
07/21FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
07/21FRESENIUS SE : JP Morgan maintains a Buy rating
MD
07/20FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan gives a Neutral rating
MD
07/20FRESENIUS SE : Berenberg remains its Buy rating
MD
07/20FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Berenberg
MD
07/14FRESENIUS MEDICAL CARE : Truist Securities Adjusts Fresenius Medical Care PT to ..
MT
07/14FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Morgan Stanley
MD
07/14FRESENIUS SE : Morgan Stanley maintains a Buy rating
MD
More news
Financials
Sales 2021 37 017 M 43 969 M 43 969 M
Net income 2021 1 791 M 2 127 M 2 127 M
Net Debt 2021 22 155 M 26 315 M 26 315 M
P/E ratio 2021 14,3x
Yield 2021 1,86%
Capitalization 25 722 M 30 578 M 30 552 M
EV / Sales 2021 1,29x
EV / Sales 2022 1,19x
Nbr of Employees 310 842
Free-Float 73,1%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | FRE | DE0005785604 | MarketScreener
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 46,14 €
Average target price 48,52 €
Spread / Average Target 5,17%
EPS Revisions
Managers and Directors
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter MŘller Independent Member-Supervisory Board